
Roche
Update in progressRO.SW (Swiss)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - General
Roche Holding AG operates in pharmaceuticals and diagnostics worldwide, including Europe, the Americas, Asia, Africa, Australia, and New Zealand. It develops medicines for anemia, cancers, dermatology, hematology, infectious and inflammatory diseases, neurology, ophthalmology, respiratory conditions, and transplantation. It also offers in vitro diagnostics, tests for cancer, diabetes, COVID-19, hepatitis, HPV, and other diseases, plus diagnostic instruments and digital health solutions. Founded 1896, Basel, Switzerland.
Company score
- Sentiment
- 2.11
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- -0.07
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 1.89
- Governance
- 0.31
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.61
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 1.36
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
No news articles are available for this company yet.
Unable to load company news.
You're all caught up!